The pathophysiology of fragile x syndrome.

Fragile X syndrome is the most common form of inherited mental retardation. The disorder is mainly caused by the expansion of the trinucleotide sequence CGG located in the 5' UTR of the FMR1 gene on the X chromosome. The abnormal expansion of this triplet leads to hypermethylation and consequent silencing of the FMR1 gene. Thus, the absence of the encoded protein (FMRP) is the basis for the phenotype. FMRP is a selective RNA-binding protein that associates with polyribosomes and acts as a negative regulator of translation. FMRP appears to play an important role in synaptic plasticity by regulating the synthesis of proteins encoded by certain mRNAs localized in the dendrite. An advancing understanding of the pathophysiology of this disorder has led to promising strategies for pharmacologic interventions.

[1]  D. Nelson,et al.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. , 2007, Experimental cell research.

[2]  Michael Lardelli,et al.  Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. , 2006, Human molecular genetics.

[3]  S. Kunes,et al.  Synaptic Protein Synthesis Associated with Memory Is Regulated by the RISC Pathway in Drosophila , 2006, Cell.

[4]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[5]  J. Dekker,et al.  The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications , 2006, Proceedings of the National Academy of Sciences.

[6]  I. Weiler,et al.  Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.

[7]  Gene W. Yeo,et al.  Noncoding RNAs in the mammalian central nervous system. , 2006, Annual review of neuroscience.

[8]  G. Merz,et al.  Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP , 2006, Journal of Cell Science.

[9]  G. Ramakers,et al.  Dendritic pathology in mental retardation: from molecular genetics to neurobiology , 2006, Genes, brain, and behavior.

[10]  R. Nicholls,et al.  The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors , 2006, Nucleic acids research.

[11]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[12]  Nancy M Bonini,et al.  Drosophila as a model for human neurodegenerative disease. , 2005, Annual review of genetics.

[13]  C. E. Pearson,et al.  Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.

[14]  E. De Schutter,et al.  Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.

[15]  G. Bassell,et al.  Localization of FMRP‐associated mRNA granules and requirement of microtubules for activity‐dependent trafficking in hippocampal neurons , 2005, Genes, brain, and behavior.

[16]  R. Frank Kooy,et al.  Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS) , 2005, Behavioural Brain Research.

[17]  S. Eddy,et al.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.

[18]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[19]  A. Gabrielian,et al.  The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter. , 2005, The Biochemical journal.

[20]  M. Epstein,et al.  Association of FMR1 repeat size with ovarian dysfunction. , 2005, Human reproduction.

[21]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[22]  R. Carroll,et al.  Metabotropic Glutamate Receptor Activation Regulates Fragile X Mental Retardation Protein and Fmr1 mRNA Localization Differentially in Dendrites and at Synapses , 2004, The Journal of Neuroscience.

[23]  Allan L Reiss,et al.  The neuroanatomy and neuroendocrinology of fragile X syndrome. , 2004, Mental retardation and developmental disabilities research reviews.

[24]  K. Cornish,et al.  Attention and language in fragile X. , 2004, Mental retardation and developmental disabilities research reviews.

[25]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[26]  G. Neri,et al.  X-Linked Mental Retardation (XLMR): From Clinical Conditions to Cloned Genes , 2004, Critical reviews in clinical laboratory sciences.

[27]  S. Ceman,et al.  Phosphorylation influences the translation state of FMRP-associated polyribosomes. , 2003, Human molecular genetics.

[28]  P. Hagerman,et al.  A cerebellar tremor/ataxia syndrome among fragile X premutation carriers , 2003, Cytogenetic and Genome Research.

[29]  L. Chen,et al.  The fragile x mental retardation protein binds and regulates a novel class of mRNAs containing u rich target sequences , 2003, Neuroscience.

[30]  A. Pastore,et al.  The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding. , 2003, Biochemistry.

[31]  É. Khandjian,et al.  82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization. , 2003, Human molecular genetics.

[32]  N. Santoro.  Mechanisms of premature ovarian failure. , 2003, Annales d'endocrinologie.

[33]  B. Oostra,et al.  The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at Synapses , 2003, Cell.

[34]  I. Weiler,et al.  RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.

[35]  W. Brown,et al.  Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. , 2003, American journal of human genetics.

[36]  A. Iacoangeli,et al.  Dendritic BC1 RNA: Functional Role in Regulation of Translation Initiation , 2002, The Journal of Neuroscience.

[37]  Lorenzo Pavone,et al.  Epilepsy in fragile X syndrome , 2002, Brain and Development.

[38]  S. Ceman,et al.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. , 2002, American journal of human genetics.

[39]  M. D. Del Bigio,et al.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.

[40]  B. Oostra,et al.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. , 2002, Nucleic acids research.

[41]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Barker.  Microsatellite DNA: a tool for population genetic analysis. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  G. Fisch,et al.  Longitudinal Changes in Cognitive and Adaptive Behavior Scores in Children and Adolescents with the Fragile X Mutation or Autism , 2002, Journal of autism and developmental disorders.

[44]  Kenneth S Kosik,et al.  Neuronal RNA Granules A Link between RNA Localization and Stimulation-Dependent Translation , 2001, Neuron.

[45]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[46]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[47]  J. Mandel,et al.  The Fragile X mental retardation protein , 2001, Brain Research Bulletin.

[48]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[49]  J. Mandel,et al.  A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[51]  I. Weiler,et al.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.

[52]  S. Ceman,et al.  Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. , 2000, Biochemical and biophysical research communications.

[53]  H. Hjalgrim,et al.  Aspects of skeletal development in fragile X syndrome fetuses. , 2000, American journal of medical genetics.

[54]  B. Oostra,et al.  Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. , 2000, Experimental cell research.

[55]  F. Tamanini,et al.  The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. , 2000, Human molecular genetics.

[56]  M. Bear,et al.  Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.

[57]  P. Hagerman,et al.  Clinical involvement and protein expression in individuals with the FMR1 premutation. , 2000, American journal of medical genetics.

[58]  S. Ceman,et al.  Isolation of an FMRP-Associated Messenger Ribonucleoprotein Particle and Identification of Nucleolin and the Fragile X-Related Proteins as Components of the Complex , 1999, Molecular and Cellular Biology.

[59]  J. Mandel,et al.  A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. , 1999, Human molecular genetics.

[60]  B. Oostra,et al.  Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. , 1999, Human molecular genetics.

[61]  S. Warren,et al.  Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells , 1999, Nature Genetics.

[62]  W. Brown,et al.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.

[63]  M. Macias,et al.  Fragile X syndrome and deletions in FMR1: new case and review of the literature. , 1997, American journal of medical genetics.

[64]  S. Warren,et al.  Prenatal diagnosis of the fragile X syndrome: loss of mutation owing to a double recombinant or gene conversion event at the FMR1 locus. , 1997, Journal of medical genetics.

[65]  R I Richards,et al.  Dynamic mutation: possible mechanisms and significance in human disease. , 1997, Trends in biochemical sciences.

[66]  J. Mandel,et al.  Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. , 1997, Human molecular genetics.

[67]  B. Oostra,et al.  The fragile X syndrome , 1997, Journal of Inherited Metabolic Disease.

[68]  I. Weiler,et al.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Hohmann,et al.  Modulation of Hippocampal Excitability and Seizures by Galanin , 2022 .

[70]  S. Warren,et al.  Characterization of the full fragile X syndrome mutation in fetal gametes , 1997, Nature Genetics.

[71]  W. Brown,et al.  Familial transmission of the FMR1 CGG repeat. , 1996, American journal of human genetics.

[72]  É. Khandjian,et al.  Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. , 1995, American journal of human genetics.

[73]  R. Nussbaum,et al.  The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.

[74]  D. Nelson,et al.  Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome , 1995, Nature Genetics.

[75]  S. Warren,et al.  Translational suppression by trinucleotide repeat expansion at FMR1 , 1995, Science.

[76]  A. Chakravarti,et al.  Down syndrome consequent to a cryptic maternal 12p;21q chromosome translocation. , 1995, American journal of medical genetics.

[77]  E. Eichler,et al.  Length of uninterrupted CGG repeats determines instability in the FMR1 gene , 1994, Nature Genetics.

[78]  S. Thibodeau,et al.  High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. , 1994, American journal of medical genetics.

[79]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[80]  S. Warren,et al.  Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles , 1994, Cell.

[81]  B. Oostra,et al.  A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. , 1994, Human molecular genetics.

[82]  Miguel Ángel Martínez,et al.  Epidermal mosaicism and Blaschko's lines. , 1994, Journal of medical genetics.

[83]  Robert I. Richards,et al.  Simple repeat DNA is not replicated simply , 1994, Nature Genetics.

[84]  C. Schwartz,et al.  An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. , 1993, Human molecular genetics.

[85]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[86]  T. Kunkel.  Slippery DNA and diseases , 1993, Nature.

[87]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[88]  E. Eichler,et al.  Fine structure of the human FMR1 gene. , 1993, Human molecular genetics.

[89]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[90]  J. Mallet,et al.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain , 1993, Nature Genetics.

[91]  A. Poustka,et al.  Fragile X syndrome without CCG amplification has an FMR1 deletion , 1992, Nature Genetics.

[92]  A. Poustka,et al.  A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. , 1992, American journal of human genetics.

[93]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[94]  N. Tommerup,et al.  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. , 1991, The New England journal of medicine.

[95]  H. Galjaard,et al.  Prenatal diagnosis of fragile X syndrome , 1991, The Lancet.

[96]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[97]  A. Roche,et al.  A YAC contig across the fragile X site defines the region of fragility. , 1991, Nucleic acids research.

[98]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[99]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[100]  D. Le Paslier,et al.  Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. , 1991, Science.

[101]  R. Hagerman,et al.  Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. , 1991, American journal of medical genetics.

[102]  C. P. Morris,et al.  Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines. , 1990, American journal of human genetics.

[103]  K. Davies,et al.  A new DNA marker tightly linked to the fragile X locus (FRAXA). , 1989, Science.

[104]  Simensen Rj,et al.  Fragile-X syndrome. , 1989 .

[105]  A. Verloes,et al.  SOTOS SYNDROME AND FRAGILE X CHROMOSOMES , 1987, The Lancet.

[106]  S. Warren,et al.  The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites. , 1987, Science.

[107]  J. Fryns,et al.  The fragile X syndrome: A study of 83 families , 1984, Clinical genetics.

[108]  N. Morton,et al.  The marker (X) syndrome: a cytogenetic and genetic analysis , 1984, Annals of human genetics.

[109]  C. Harrison,et al.  The fragile X: a scanning electron microscope study. , 1983, Journal of medical genetics.

[110]  P. Hagerman,et al.  The Fragile X Syndrome: History, Diagnosis, and Treatment , 1983, Journal of developmental and behavioral pediatrics : JDBP.

[111]  N. Tommerup,et al.  X-Linked mental retardation with fragile X. a pedigree showing transmission by apparently unaffected males and partial expression in female carriers , 1981, Human Genetics.

[112]  G. Sutherland.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. , 1977, Science.

[113]  D. Pitt.  X‐Linked Mental Retardation and Verbal Disability , 1975 .

[114]  H. Lubs.  A marker X chromosome. , 1969, American journal of human genetics.

[115]  J. Bell,et al.  A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE , 1943, Journal of neurology and psychiatry.

[116]  J. Haldane,et al.  A Clinical and Genetic Study of 1,280 Cases of Mental Defect , 1938, Mental Welfare.

[117]  N. Morton,et al.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males , 2004, Human Genetics.

[118]  K. Svoboda,et al.  Structure and function of dendritic spines. , 2002, Annual review of physiology.

[119]  SumanLee.  Human FEN-1 can process the 5'-flap DNA of CTG/CAG triplet repeat derived from human genetic diseases by length and sequence dependent manner , 2002 .

[120]  Alcino J. Silva,et al.  Genetic approaches to molecular and cellular cognition: a focus on LTP and learning and memory. , 2002, Annual review of genetics.

[121]  O. Steward,et al.  Protein synthesis at synaptic sites on dendrites. , 2001, Annual review of neuroscience.

[122]  H. Zoghbi,et al.  Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.

[123]  J. Mandel,et al.  Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. , 1996, Human molecular genetics.

[124]  Rosalind,et al.  Two new cases of FMR1 deletion associated with mental impairment. , 1995, American journal of human genetics.

[125]  S. Thibodeau,et al.  The fragile X premutation in carriers and its effect on mutation size in offspring. , 1995, American journal of human genetics.

[126]  Edwin Reyniers,et al.  A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.

[127]  T. Kunkel.  Nucleotide repeats. Slippery DNA and diseases. , 1993, Nature.

[128]  E. Eichler,et al.  Alternative splicing in the fragile X gene FMR1. , 1993, Human molecular genetics.

[129]  R. Hagerman,et al.  Aortic root dilatation and mitral valve prolapse in the fragile X syndrome. , 1986, American journal of medical genetics.

[130]  C. Bloomfield,et al.  Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. , 1985, Cytogenetics and cell genetics.

[131]  Lehrke Rg.  X-linked mental retardation and verbal disability. , 1974 .